These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 3253218)

  • 1. Blood levels of progabide and its active metabolite in epileptic patients: relationships to the therapeutic outcome.
    Benassi E; Morselli PL; Besio G; Bianchetti G; Loeb C
    Int J Clin Pharmacol Res; 1988; 8(6):409-13. PubMed ID: 3253218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary observations on the activity of progabide, administered as monotherapy in complex partial seizures.
    Benassi E; Besio G; Bo GP; Cocito L; Maffini M; Mainardi P; Morselli PL; Loeb C
    Int J Clin Pharmacol Res; 1988; 8(5):353-61. PubMed ID: 3068161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of epilepsy: open multicenter trial with progabide in epileptic patients.
    Musch B; Cambier J; Loiseau P; Fournier V; Beaussart M; Benoit C; Broglin D; Cenraud M; Chatel M; Deville MC
    Eur Neurol; 1987; 26(2):113-9. PubMed ID: 3830207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic failure, treatment and non-treatment of childhood epilepsy].
    Garaizar C; Pérez-García J; Gil-Antón J; Prats JM
    Rev Neurol; 1998 Sep; 27(157):467-72. PubMed ID: 9774821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progabide and SL 75102 binding to plasma proteins and red blood cells in humans.
    Hamberger C; Barre J; Brandebourger M; Urien S; Taiclet A; Thenot JP; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):178-84. PubMed ID: 3583466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progabide for refractory partial epilepsy: a controlled add-on trial.
    Schmidt D; Utech K
    Neurology; 1986 Feb; 36(2):217-21. PubMed ID: 3511402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of refractory infantile epilepsy with vigabatrin in a series of 55 patients].
    López-Valdés E; Hernández-Laín A; Simón R; Porta J; Mateos F
    Rev Neurol; 1996 Oct; 24(134):1255-7. PubMed ID: 8983724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH; Ahmed MM; Mohammed SA
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled study of progabide in partial seizures: methodology and results.
    Leppik IE; Dreifuss FE; Porter R; Bowman T; Santilli N; Jacobs M; Crosby C; Cloyd J; Stackman J; Graves N
    Neurology; 1987 Jun; 37(6):963-8. PubMed ID: 3295590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.
    Martínez-Lage JM; Bossi L; Morales G; Martínez Vila E; Orofiamma B; Viteri C
    Epilepsia; 1984 Oct; 25(5):586-93. PubMed ID: 6383790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for the use of gamma-aminobutyric acid (GABA)-agonists in convulsant disorders.
    Lloyd KG; Munari C; Worms P; Bossi L; Morselli PL
    Prog Clin Biol Res; 1983; 124():285-97. PubMed ID: 6410408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled, cross-over trial of progabide as add-on therapy in epileptic patients.
    de Pasquet EG; Scaramelli A; de Cáceres MP; L'Héritier C; Feldman S; Santana R; Aguilar J; Musch B; Morselli PL
    Epilepsia; 1991; 32(1):133-9. PubMed ID: 1985823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F; Sopranzi N
    Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of event related potentials in evaluation of subclinical cognitive dysfunction in epileptic patients.
    Ozmenek OA; Nazliel B; Leventoğlu A; Bilir E
    Acta Neurol Belg; 2008 Jun; 108(2):58-63. PubMed ID: 18795598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of progabide and its acid metabolite by reversed-phase high-performance liquid chromatography.
    Decourt JP; Mura P; Papet Y; Piriou A; Reiss D
    J Chromatogr; 1990 Apr; 527(1):214-9. PubMed ID: 2365784
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic monitoring of antiepileptic drugs: a comparison between a Czech and a Swedish University Hospital.
    Koristkova B; Bergman U; Grundmann M; Brozmanova H; Sjöqvist F
    Ther Drug Monit; 2006 Oct; 28(5):594-8. PubMed ID: 17038871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability.
    Ylinen A
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():46-9. PubMed ID: 10030432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of progabide and its main acid metabolite in biological fluids using high-performance liquid chromatography and electrochemical detection. Application to the measurement of blood/plasma partition ratio.
    Padovani P; Deves C; Bianchetti G; Thenot JP; Morselli PL
    J Chromatogr; 1984 Jun; 308():229-39. PubMed ID: 6746816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.